Yasushi Totoki
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Yasushi Totoki has a total of 131 co-authors. Here are the top co-authors by number of shared publications:
Hiromi Nakamura
Division of Cancer Genomics, National Cancer Center Research Institute, Tokyo, Japan
53 shared publications- Mihoko Saito-Adachi
Division of Cancer Genomics, National Cancer Center Research Institute, Tokyo, Japan
52 shared publications Natsuko Hama
Division of Cancer Genomics, National Cancer Center Research Institute, Tokyo, Japan
52 shared publications- Shinichi Yachida
Department of Cancer Genome Informatics, Graduate School of Medicine, Osaka University, Osaka, Japan
51 shared publications Tatsuhiro Shibata
48 shared publicationsAyaka Shimomura
47 shared publications
Latest Publications
- Open Access
- 10 August 2026
- Published by Springer Nature in Nature Genetics
- Vol. 58 (9) , 2211-2225
Prevalence and chronology of colibactin-associated mutational processes and their microbiome spectra in Japanese colorectal cancer
- 10 August 2026
- Published by Springer Nature in Nature Genetics
- Vol. 58 (9) , 2211-2225
Open AccessPrevalence and chronology of colibactin-associated mutational processes and their microbiome spectra in Japanese colorectal cancer
- Open Access
- 2 September 2024
- Published by Springer Nature in Research Square
Microbiome spectra and prevalent colibactin-associated mutational process in Japanese colorectal cancer
The recent rapid increase in colorectal cancer (CRC) cases, particularly among young patients, poses a significant public health concern in Japan and other countries. The association between the gut microbiota and CRC has been well established. Here, we present a detailed analysis of this association by combining whole-genome sequencing (WGS) and whole-transcriptome data from CRC tissues with whole-genome metagenomic sequencing (WGMS) of fecal samples. The utilization of explanatory artificial intelligence analysis enabled classification of the disease into four distinct subtypes. This microbiome-based subclassification was found to be correlated with specific clinical and molecular characteristics, and included a subgroup having a higher proportion of younger patients with an unfavorable prognosis. The WGS analysis revealed mutational signatures (SBS88 and ID18) associated with colibactin exposure; these were considered early clonal events and found in 70.3% of patients (97 out of 138), with higher prevalence in the younger subtype. APC hotspot mutation and frameshift deletion, which matched the colibactin signature and the colibactin-specific motif, were observed in 12 patients (8.7%). CRCs exhibiting colibactin-associated mutational signatures were more common in younger patients and had an immunosuppressive microenvironment. Colibactin exposure is a highly prevalent but modifiable risk factor for CRC in the Japanese population.
- 2 September 2024
- Published by Springer Nature in Research Square
Open AccessMicrobiome spectra and prevalent colibactin-associated mutational process in Japanese colorectal cancer
The recent rapid increase in colorectal cancer (CRC) cases, particularly among young patients, poses a significant public health concern in Japan and other countries. The association between the gut microbiota and CRC has been well established. Here, we present a detailed analysis of this association by combining whole-genome sequencing (WGS) and whole-transcriptome data from CRC tissues with whole-genome metagenomic sequencing (WGMS) of fecal samples. The utilization of explanatory artificial intelligence analysis enabled classification of the disease into four distinct subtypes. This microbiome-based subclassification was found to be correlated with specific clinical and molecular characteristics, and included a subgroup having a higher proportion of younger patients with an unfavorable prognosis. The WGS analysis revealed mutational signatures (SBS88 and ID18) associated with colibactin exposure; these were considered early clonal events and found in 70.3% of patients (97 out of 138), with higher prevalence in the younger subtype. APC hotspot mutation and frameshift deletion, which matched the colibactin signature and the colibactin-specific motif, were observed in 12 patients (8.7%). CRCs exhibiting colibactin-associated mutational signatures were more common in younger patients and had an immunosuppressive microenvironment. Colibactin exposure is a highly prevalent but modifiable risk factor for CRC in the Japanese population.
- Open Access
- 16 December 2023
- Published by Springer Nature in Nature Communications
- Vol. 14 (1) , 1-15
Genomic and epigenomic integrative subtypes of renal cell carcinoma in a Japanese cohort
Renal cell carcinoma (RCC) comprises several histological types characterised by different genomic and epigenomic aberrations; however, the molecular pathogenesis of each type still requires further exploration. We perform whole-genome sequencing of 128 Japanese RCC cases of different histology to elucidate the significant somatic alterations and mutagenesis processes. We also perform transcriptomic and epigenomic sequencing to identify distinguishing features, including assay for transposase-accessible chromatin sequencing (ATAC-seq) and methyl sequencing. Genomic analysis reveals that the mutational signature differs among the histological types, suggesting that different carcinogenic factors drive each histology. From the ATAC-seq results, master transcription factors are identified for each histology. Furthermore, clear cell RCC is classified into three epi-subtypes, one of which expresses highly immune checkpoint molecules with frequent loss of chromosome 14q. These genomic and epigenomic features may lead to the development of effective therapeutic strategies for RCC.
- 16 December 2023
- Published by Springer Nature in Nature Communications
- Vol. 14 (1) , 1-15
Open AccessGenomic and epigenomic integrative subtypes of renal cell carcinoma in a Japanese cohort
Renal cell carcinoma (RCC) comprises several histological types characterised by different genomic and epigenomic aberrations; however, the molecular pathogenesis of each type still requires further exploration. We perform whole-genome sequencing of 128 Japanese RCC cases of different histology to elucidate the significant somatic alterations and mutagenesis processes. We also perform transcriptomic and epigenomic sequencing to identify distinguishing features, including assay for transposase-accessible chromatin sequencing (ATAC-seq) and methyl sequencing. Genomic analysis reveals that the mutational signature differs among the histological types, suggesting that different carcinogenic factors drive each histology. From the ATAC-seq results, master transcription factors are identified for each histology. Furthermore, clear cell RCC is classified into three epi-subtypes, one of which expresses highly immune checkpoint molecules with frequent loss of chromosome 14q. These genomic and epigenomic features may lead to the development of effective therapeutic strategies for RCC.
- Open Access
- 22 June 2023
- Published by Springer Nature in Nature Communications
- Vol. 14 (1) , 1-13
Oncogenic structural aberration landscape in gastric cancer genomes
Structural variants (SVs) are responsible for driver events in gastric cancer (GC); however, their patterns and processes remain poorly understood. Here, we examine 170 GC whole genomes to unravel the oncogenic structural aberration landscape in GC genomes and identify six rearrangement signatures (RSs). Non-random combinations of RSs elucidate distinctive GC subtypes comprising one or a few dominant RS that are associated with specific driver events (BRCA1/2 defects, mismatch repair deficiency, and TP53 mutation) and epidemiological backgrounds. Twenty-seven SV hotspots are identified as GC driver candidates. SV hotspots frequently constitute complexly clustered SVs involved in driver gene amplification, such as ERBB2, CCNE1, and FGFR2. Further deconstruction of the locally clustered SVs uncovers amplicon-generating profiles characterized by super-large SVs and intensive segmental amplifications, contributing to the extensive amplification of GC oncogenes. Comprehensive analyses using adjusted SV allele frequencies indicate the significant involvement of extra-chromosomal DNA in processes linked to specific RSs.
- 22 June 2023
- Published by Springer Nature in Nature Communications
- Vol. 14 (1) , 1-13
Open AccessOncogenic structural aberration landscape in gastric cancer genomes
Structural variants (SVs) are responsible for driver events in gastric cancer (GC); however, their patterns and processes remain poorly understood. Here, we examine 170 GC whole genomes to unravel the oncogenic structural aberration landscape in GC genomes and identify six rearrangement signatures (RSs). Non-random combinations of RSs elucidate distinctive GC subtypes comprising one or a few dominant RS that are associated with specific driver events (BRCA1/2 defects, mismatch repair deficiency, and TP53 mutation) and epidemiological backgrounds. Twenty-seven SV hotspots are identified as GC driver candidates. SV hotspots frequently constitute complexly clustered SVs involved in driver gene amplification, such as ERBB2, CCNE1, and FGFR2. Further deconstruction of the locally clustered SVs uncovers amplicon-generating profiles characterized by super-large SVs and intensive segmental amplifications, contributing to the extensive amplification of GC oncogenes. Comprehensive analyses using adjusted SV allele frequencies indicate the significant involvement of extra-chromosomal DNA in processes linked to specific RSs.
- Open Access
- 4 April 2023
- Published by American Association for Cancer Research (AACR)
Supplementary Data from Comprehensive Genomic Profiling of Neuroendocrine Carcinomas of the Gastrointestinal System
Supplementary Data from Comprehensive Genomic Profiling of Neuroendocrine Carcinomas of the Gastrointestinal System
- 4 April 2023
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Data from Comprehensive Genomic Profiling of Neuroendocrine Carcinomas of the Gastrointestinal System
Supplementary Data from Comprehensive Genomic Profiling of Neuroendocrine Carcinomas of the Gastrointestinal System
- Open Access
- 4 April 2023
- Published by American Association for Cancer Research (AACR)
Supplementary Data from Comprehensive Genomic Profiling of Neuroendocrine Carcinomas of the Gastrointestinal System
Supplementary Data from Comprehensive Genomic Profiling of Neuroendocrine Carcinomas of the Gastrointestinal System
- 4 April 2023
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Data from Comprehensive Genomic Profiling of Neuroendocrine Carcinomas of the Gastrointestinal System
Supplementary Data from Comprehensive Genomic Profiling of Neuroendocrine Carcinomas of the Gastrointestinal System
- Open Access
- 4 April 2023
- Published by American Association for Cancer Research (AACR)
Supplementary Data from Comprehensive Genomic Profiling of Neuroendocrine Carcinomas of the Gastrointestinal System
Supplementary Data from Comprehensive Genomic Profiling of Neuroendocrine Carcinomas of the Gastrointestinal System
- 4 April 2023
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Data from Comprehensive Genomic Profiling of Neuroendocrine Carcinomas of the Gastrointestinal System
Supplementary Data from Comprehensive Genomic Profiling of Neuroendocrine Carcinomas of the Gastrointestinal System
- Open Access
- 4 April 2023
- Published by American Association for Cancer Research (AACR)
Supplementary Data from Comprehensive Genomic Profiling of Neuroendocrine Carcinomas of the Gastrointestinal System
Supplementary Data from Comprehensive Genomic Profiling of Neuroendocrine Carcinomas of the Gastrointestinal System
- 4 April 2023
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Data from Comprehensive Genomic Profiling of Neuroendocrine Carcinomas of the Gastrointestinal System
Supplementary Data from Comprehensive Genomic Profiling of Neuroendocrine Carcinomas of the Gastrointestinal System
- Open Access
- 4 April 2023
- Published by American Association for Cancer Research (AACR)
Supplementary Data from Comprehensive Genomic Profiling of Neuroendocrine Carcinomas of the Gastrointestinal System
Supplementary Data from Comprehensive Genomic Profiling of Neuroendocrine Carcinomas of the Gastrointestinal System
- 4 April 2023
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Data from Comprehensive Genomic Profiling of Neuroendocrine Carcinomas of the Gastrointestinal System
Supplementary Data from Comprehensive Genomic Profiling of Neuroendocrine Carcinomas of the Gastrointestinal System
- Open Access
- 4 April 2023
- Published by American Association for Cancer Research (AACR)
Supplementary Data from Comprehensive Genomic Profiling of Neuroendocrine Carcinomas of the Gastrointestinal System
Supplementary Data from Comprehensive Genomic Profiling of Neuroendocrine Carcinomas of the Gastrointestinal System
- 4 April 2023
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Data from Comprehensive Genomic Profiling of Neuroendocrine Carcinomas of the Gastrointestinal System
Supplementary Data from Comprehensive Genomic Profiling of Neuroendocrine Carcinomas of the Gastrointestinal System